Showing 1 - 20 results of 46,098 for search '(( 50 ((ms decrease) OR (_ decrease)) ) OR ((( 12 h decrease ) OR ( _ akt decrease ))))*', query time: 0.78s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    AKT inhibition decreases neuroblast populations. by Maria R. Aburto (186884)

    Published 2012
    “…<p>(<b>A</b>) SOX2 expression upon PI3K-AKT inhibition. Otic vesicles were isolated from HH18 chicken embryos, made quiescent and cultured for 20 h in serum-free culture medium without additions (0S, a) or in the presence of IGF-I (10 nM, b), LY294002 (LY, 25 µM, c) or AKTi VIII (AKTi, 50 µM, d). …”
  5. 5

    Loss of Trib2 decreases disease latency of Notch-driven T-ALL. by Sarah J. Stein (3168600)

    Published 2016
    “…Mice with a body condition score of ≤2 and decreased mobility were euthanized (n = 8 Trib2<sup>+/+</sup> and n = 12 Trib2<sup>-/-</sup> recipients. …”
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Image_1_IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt.TIF by Renée H. Fiechter (10230473)

    Published 2021
    “…We observed numerical decreases of all infiltrating cell subtypes at week 12, reaching statistical significance for CD68+ sublining macrophages. …”
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    H<sub>2</sub>O<sub>2</sub> decreased PC12 cells viability. by Guohua Ji (436621)

    Published 2013
    “…<p>MTT assay showed that 12.5∼25 µM H<sub>2</sub>O<sub>2</sub> treatment had no obvious effect, while 50 µM, 100 µM, and 200 µM H<sub>2</sub>O<sub>2</sub> treatment resulted in cell viability decrease by 7%, 15% and 16%, respectively. …”
  17. 17

    Activation of AKT, decrease in FOXO and activation of glycolytic genes in CERT heterozygous mice. by Niraj K. Nirala (424266)

    Published 2013
    “…A simple graphical model depicting metabolic reprogramming in <i>dcerk<sup>1</sup></i> due to increased AKT activation and decreased FOXO to maintain energy balance. …”
  18. 18
  19. 19

    SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

    Published 2021
    “…(b) Prostate cancer incidence in male SLE cohort is significantly decreased by SLE status (OR 0.23, 95% CI 0.089, 0.50, p = 0.0053).…”
  20. 20